N95 Masks for Lung Health While Golfing During Wildfire Season

May 26, 2026 updated by: Phil Chilibeck, University of Saskatchewan

A Pilot / Feasibility Study on Cardiorespiratory Health of Golfers During Wildfire Season

Lung health is negatively affected during wildfire season by increased smoke pollution. Wearing N95 masks protects lung health in the short-term. The purpose of our study is to assess whether wearing of N95 facemasks on days with moderate to high air pollution in people who go outside to golf on a regular basis (two or more times per week) for two months during the wildfire season projects lung health.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Wildfire smoke negatively affects lung health. Across North American, millions of people are exposed to wildfire smoke most summers. The purpose of our study is to determine whether people who golf regularly (two or more times per week) can use N95 masks to protect their lungs from wildfire smoke. Forty regular golfers will be randomized to receive N95 masks or not to receive masks. All participants will be told to follow guidelines for outdoor activity based on Air Quality Health Index readings. Those randomized to wear N95 facemasks will be asked to wear these on days they golf where Air Quality Health Index indicates moderate risk or higher. The main outcome is compliance with wearing the N95 mask. Secondary outcomes include changes in lung function, blood pressure, and respiratory symptoms over two months.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • SK - Saskatchewan
      • Saskatoon, SK - Saskatchewan, Canada, S7N 5B2
        • Recruiting
        • University of Saskatchewan
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Golf on a regular basis (two or more times per week)

Exclusion Criteria:

  • Smoker

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: N95 mask
N95 masks will be worn outdoors when Air Quality Health Index indicates moderate risk or higher (4 or higher)
N95 mask to be worn outside when golfing when Air Quality Health Index reading indicates moderate risk or higher
No Intervention: No N95 mask
No N95 masks will be provided to participants

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in compliance with wearing of N95 masks (number of times divided by days with moderate or higher air pollution)
Time Frame: 8 weeks
compliance with wearing the N95 masks
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in forced expiratory volume in one second (L)
Time Frame: 8 weeks
Force expiratory volume in one second measured with spirometry
8 weeks
Change in forced vital capacity (mL)
Time Frame: 8 weeks
Forced vital capacity measured by spirometry
8 weeks
Change in forced expiratory flow at 25% to 75% of vital capacity (mL)
Time Frame: 8 weeks
forced expiratory flow at 25% to 75% of vital capacity measured by spirometry
8 weeks
Change in respiratory symptoms (score out of 12)
Time Frame: 8 weeks
Respiratory symptoms determined by the Dyspnoea-12 questionnaire
8 weeks
Change in systolic blood pressure (mmHg)
Time Frame: 8 weeks
Systolic blood pressure measured by an automatic sphygmomanometer
8 weeks
Change in diastolic blood pressure (mmHg)
Time Frame: 8 weeks
Diastolic blood pressure measured by an automatic sphygmomanometer
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Philip Chilibeck, PhD, University of Saskatchewan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 26, 2026

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

May 26, 2026

First Submitted That Met QC Criteria

May 26, 2026

First Posted (Actual)

June 2, 2026

Study Record Updates

Last Update Posted (Actual)

June 2, 2026

Last Update Submitted That Met QC Criteria

May 26, 2026

Last Verified

May 1, 2026

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bronchial Asthma

Clinical Trials on N95 mask

Subscribe